Patent ID: 8541415

Claim:
A method for treating HIV-1 in a subject in need thereof, comprising (a) identifying a subject infected with HIV-1 and then (b) administering to said subject a therapeutic dose of a Formula I compound wherein Cy 1 is selected from the group consisting of aryl and heteroaryl, wherein the aryl or heteroaryl group is optionally substituted with one or more members selected from the group consisting of —OH, chloroacetyl halogen, sulfonic acid, nitro and —O-alkyl; Cy 2 is an aryl optionally substituted with one or more members selected from the group consisting of halogen, alkyl, amino and —O-alkyl; R 5 , R 6 , R 7 , and R 8 are independently selected from the group consisting of hydrogen and —OR 11 , and R 11 is selected from the group consisting of optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, optionally substituted arylalkyl, optionally substituted heteroaryl, and optionally substituted heteroarylalkyl.